0001104659-23-062755.txt : 20230621 0001104659-23-062755.hdr.sgml : 20230621 20230519171820 ACCESSION NUMBER: 0001104659-23-062755 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230519 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AGILE THERAPEUTICS INC CENTRAL INDEX KEY: 0001261249 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 BUSINESS PHONE: 609-683-1880 MAIL ADDRESS: STREET 1: 500 COLLEGE ROAD EAST STREET 2: SUITE 310 CITY: PRINCETON STATE: NJ ZIP: 08540-6635 CORRESP 1 filename1.htm

  

 

 

May 19, 2023

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporation Finance

Washington, D.C. 20549

 

  Re: Agile Therapeutics, Inc.
    Registration Statement on Form S-1 (File No. 333-271249)
    Concurrence in Acceleration Request

 

Ladies and Gentlemen:

 

H.C. Wainwright & Co., LLC (“Wainwright”), as placement agent for the referenced offering, hereby concurs in the request by Agile Therapeutics, Inc. that the effective date of the above-referenced registration statement be accelerated to Monday, May 22, 2023, at 3:00 p.m. (Washington, D.C. time), or as soon as practicable thereafter, pursuant to Rule 461 under the Securities Act. Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement. 

 

  Very truly yours,
   
  H.C. WAINWRIGHT & CO., LLC
     
  By: /s/ Edward D. Silvera
    Name: Edward D. Silvera
    Title: Chief Operating Officer

 

 

GRAPHIC 2 tm2312690d5_correspimg001.jpg GRAPHIC begin 644 tm2312690d5_correspimg001.jpg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end